NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MyabA.01026.a: Probable 4-aminobutyrate aminotransferase (GabT)

Target Characteristics

from organism: Mycobacterium abscessus ATCC 19977 / DSM 44196
most recent status: soluble
center reference id: MyabA.01026.a
is community request: False
associated disease: Skin abscess
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyabA.01026.a.A1.GE30383 Full length( MyabA.01026.a ) 1 452 GE30383
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
OrthoMCL: OG5_128761
PATRIC ID: fig|36809.5.peg.859
RefSeq: YP_001701569.1
UniProt: B1MI93

Enzyme & Pathway Information

Pathway Pathway ID EC Number
superpathway of 4-aminobutanoate degradation 4AMINOBUTMETAB-PWY 2.6.1.19
superpathway of L-arginine, putrescine, and 4-aminobutanoate degradation ARGDEG-PWY 2.6.1.19
beta-alanine degradation I BETA-ALA-DEGRADATION-I-PWY 2.6.1.19
GABA shunt GLUDEG-I-PWY 2.6.1.19
superpathway of L-arginine and L-ornithine degradation ORNARGDEG-PWY 2.6.1.19
nicotine degradation I (pyridine pathway) P181-PWY 2.6.1.19
glutamate degradation IX (via 4-aminobutyrate) PWY3O-210 2.6.1.19
L-glutamate degradation IV PWY-4321 2.6.1.19
4-aminobutanoate degradation V PWY-5022 2.6.1.19
4-aminobutanoate degradation I PWY-6535 2.6.1.19
4-aminobutanoate degradation III PWY-6536 2.6.1.19
4-aminobutanoate degradation II PWY-6537 2.6.1.19
L-valine degradation I VALDEG-PWY 2.6.1.22

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MTSVYSLQGG PAVAQVRRMA TEVPGPRSRE LAERRAAALP AGLVSGAGVY AAAAGGGVLV DVDGNSFLDL GSGIAVTTVG NSAPAVVARV AAQAQRFTHT CFLATPYEQY LEVAETLNRI TPGDHEKRTA LFNTGAEAVE NAVKYARVAT ARPAVVVFDH AFHGRSLMTM TMTAKQAPYR RGFGPFAPEV YRAPMAHPYR WPSGAENCAS DAFRQFASLV DNQIGAEAVA CVVVEPIQGE GGFIVPAPGF LAMVADFCRA RGILLVADEV QTGIARTGAW FASEHEQLVP DLVTTAKGLA GGLPLAAVTG RADVMDAAHP GGIGGTFSGN PLSCAAALGV FEEIETHDLL RRAADMGEML LREMRGISAE TGLIGDIRGR GAMIAAELVV PGTDSPNREA VIQILKYCQD NGVLVLSAGT YGNVLRFLPP LSMPDELLQE ALAVLRDAFR NL

NT Sequence
ATGACCTCGG TGTATAGCCT CCAGGGAGGG CCGGCAGTGG CCCAGGTGCG ACGAATGGCG ACGGAAGTGC CTGGGCCACG CTCGCGCGAG CTCGCCGAGC GCCGCGCAGC GGCGTTGCCA GCCGGCCTGG TCAGCGGTGC CGGTGTGTAT GCCGCCGCGG CGGGCGGCGG CGTACTGGTC GATGTCGACG GCAACAGCTT TCTGGATCTG GGCAGCGGCA TTGCCGTCAC CACGGTGGGC AACAGCGCAC CTGCGGTGGT TGCCCGTGTG GCCGCGCAGG CTCAACGGTT CACCCACACA TGCTTTCTGG CGACGCCCTA CGAGCAGTAC CTGGAGGTCG CCGAGACACT CAACCGAATC ACTCCCGGGG ACCACGAGAA GCGCACCGCG CTGTTCAACA CCGGTGCCGA AGCGGTTGAG AACGCGGTCA AGTACGCCCG GGTGGCGACG GCCCGCCCGG CGGTGGTTGT TTTCGATCAT GCCTTCCATG GCCGGTCGCT GATGACCATG ACCATGACCG CCAAACAGGC TCCGTACCGT CGGGGTTTCG GGCCGTTCGC TCCGGAGGTG TACCGGGCAC CCATGGCCCA CCCCTATCGG TGGCCGTCCG GAGCCGAGAA CTGCGCCTCG GACGCGTTCC GCCAGTTCGC GTCCCTGGTC GACAACCAGA TCGGTGCCGA AGCGGTGGCC TGTGTGGTGG TGGAGCCGAT CCAGGGCGAG GGCGGCTTTA TCGTCCCGGC GCCCGGATTC TTGGCGATGG TTGCCGACTT CTGCCGGGCG CGTGGCATCC TGTTGGTCGC CGACGAAGTC CAAACCGGTA TTGCCCGGAC CGGTGCATGG TTCGCCTCCG AGCACGAACA GCTGGTACCC GACCTCGTCA CCACCGCGAA GGGGCTTGCG GGCGGACTGC CTCTGGCTGC GGTAACCGGC CGCGCCGACG TCATGGACGC CGCGCATCCG GGTGGTATCG GTGGAACCTT CAGTGGCAAC CCGCTTTCCT GTGCGGCGGC ACTCGGCGTC TTCGAAGAGA TCGAGACCCA CGACCTGCTC AGGCGTGCCG CCGATATGGG CGAGATGTTG CTTCGGGAGA TGCGTGGCAT CTCCGCGGAG ACCGGCCTGA TCGGAGACAT CCGTGGGCGC GGCGCGATGA TCGCTGCCGA GCTGGTGGTG CCGGGCACCG ACTCGCCGAA TCGTGAAGCG GTGATACAGA TCTTGAAGTA TTGCCAGGAC AACGGTGTGC TGGTGCTTTC TGCTGGAACG TACGGCAATG TGCTGCGATT CCTGCCGCCG CTGTCCATGC CGGACGAGCT GCTGCAAGAG GCCCTCGCCG TGCTGCGCGA CGCGTTCCGG AACCTC

© 2022 Seattle Children's Research Institute. All rights reserved.